Climb BioCLYM
那斯達克 · USD
1.45
+0.05
(+3.57%)
收盤 08/02 03:58 (UTC+8)
盤後
0
0
(0%)
08/02 03:58 (UTC+8)
Climb BioCLYM
1.45
+0.05
(+3.57%)
財務數據
損益表
- -
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | 0 | - |
營業成本 | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | 0 | - |
營業費用 | - | - | - | - | - | 5,122 | 5,001 | 6,714 | - |
研發費用 | 17,327 | 5,959 | 6,240 | 1,046 | 1,091 | 3,127 | 2,876 | 3,688 | - |
推銷及管理費用 | 5,691 | 4,952 | 5,492 | 3,667 | 1,914 | 1,995 | 2,125 | 3,026 | - |
非經常性項目費用 | - | - | - | 51,659 | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - |
營業利益 | -23,018 | -10,911 | -11,732 | -56,372 | -3,005 | -5,122 | -5,001 | -6,714 | - |
其他收入及費用 | 2,237 | 2,495 | 2,837 | 1,483 | 1,308 | 1,481 | 1,033 | - | - |
利息費用 | - | - | - | - | - | - | - | - | - |
稅前純益 | -20,781 | -8,416 | -8,895 | -54,889 | -1,697 | -3,641 | -3,968 | -5,220 | - |
所得稅 | - | - | - | - | - | - | - | - | - |
稅後純益 | -20,781 | -8,416 | -8,895 | -54,889 | -1,697 | -3,641 | -3,968 | -5,220 | - |
基本每股稅後盈餘(元) | -0.31 | -0.13 | -0.13 | -1.81 | -0.06 | - | -0.15 | -0.19 | -0.84 |
稀釋每股稅後盈餘(元) | -0.31 | 0.04 | 0.38 | -1.89 | -0.06 | -0.13 | -0.14 | -0.19 | -0.84 |
基本平均股數(千股) | 67462.00 | 64738.00 | 67014.00 | 30349.00 | 27638.00 | - | 27071.00 | 26840.00 | 26535.00 |
稀釋平均股數(千股) | 67462.00 | 64738.00 | 67014.00 | 30349.00 | 27638.00 | - | 27071.00 | 26840.00 | 26535.00 |
還原基本每股稅後盈餘(元) | -0.31 | -0.13 | -0.13 | -1.81 | -0.06 | - | -0.15 | -0.19 | -0.84 |
還原稀釋每股稅後盈餘(元) | -0.31 | 0.04 | 0.38 | -1.89 | -0.06 | -0.13 | -0.14 | -0.19 | -0.84 |
還原基本平均股數(千股) | 67,462 | 64,738 | 67,014 | 30,349 | 27,638 | - | 27,071 | 26,840 | 26,535 |
還原稀釋平均股數(千股) | 67,462 | 64,738 | 67,014 | 30,349 | 27,638 | - | 27,071 | 26,840 | 26,535 |
EBITDA(千元) | -21,450 | -8,941 | -9,064 | -54,889 | -1,760 | -3,987 | -4,721 | -5,220 | 0 |